Lung Cancer (SMC, Cancer Research 2016)

Summary

Lung Cancer (SMC, Cancer Research 2016) is a study catalogued by cBioPortal DataHub under the cancer-type code lung. EvidenceHelix groups it with lung and pleura studies.

Study description

Whole exome and whole transcriptome sequencing of primary and multiple metastatic lymph node samples from 6 lung cancer patients with their matched normals.

Text as published in the source's study metadata.

Citation & PubMed

Sang-Won et al. Cancer Research 2016

Linked PubMed records: PMID 27634761

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

lung_smc_2016

Short name

lung (SMC 2016)

Source cancer-type code

lung

Reference genome

not given

Source access groups

PUBLIC

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Sang-Won et al. Cancer Research 2016

• PubMed record 27634761 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Small Cell Lung Cancer (UC, Nature 2024)

  Whole genome and whole exome sequencing of 160 small cell lung cancer tumors and their matched normals from 65 patients.

  Lung and pleuraOther published and consortium studiesSource code lungPubMed 1

• Atypical Small Cell Lung Cancer (MSK, Cancer Discov 2024)

  Targeted sequencing of 31 atypical small cell lung cancers lacking RB1 and TP53 co-inactivation and their matched normals via MSK-IMPACT, including structural variant analysis via whole-genome sequencing. This data is…

  Lung and pleuraMSK studiesSource code lungPubMed 1

• Lung Adenocarcinoma (MSK Mind,Nature Cancer 2022)

  Multimodality tools to predict response to PD-(L)1 blockade in patients with lung adenocarcinoma.

  Lung and pleuraMSK studiesSource code lungPubMed 1

• Lung Adenocarcinoma (Broad, Cell 2012)

  Whole-exome and/or whole-genome sequencing of 183 lung adenocarcinomas and matched normal tissue pairs.

  Lung and pleuraOther published and consortium studiesSource code luadPubMed 1

• Lung Adenocarcinoma (CAS, Cell 2020)

  Whole-exome sequencing of 103 lung adenocarcinoma cases and their matched normals in Chinese patients.

  Lung and pleuraOther published and consortium studiesSource code luadPubMed 1

• Lung Adenocarcinoma (CPTAC, Cell 2020)

  Whole genome (WGS) or whole exome sequencing (WES) of 110 tumors and 101 matched normal adjacent tissues in lung adenocarcinoma. Proteogenomic characterization generated by CPTAC.

  Lung and pleuraOther published and consortium studiesSource code luadPubMed 1

• Lung Adenocarcinoma (OncoSG, Nat Genet 2020)

  Whole-exome and transcriptome sequencing of 305 east asian lung adenocarcinomas with matched normals. Courtesy of OncoSG (https://src.gisapps.org/OncoSG/). Lung Cancer Consortium Singapore (LCCS).

  Lung and pleuraOther published and consortium studiesSource code luadPubMed 1

• Lung Adenocarcinoma (TSP, Nature 2008)

  Targeted sequencing of 163 lung adenocarcinoma tumor/normal pairs. Generated by WashU/Broad.

  Lung and pleuraOther published and consortium studiesSource code luadPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.